ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PARADIGM RECEIVES POSTIVE FEEDBACK FROM FDA TYPE C MEETING
Published: 18/12/20, 08:40am (AEST)•3 pages